The Efficacy of Cinacalcet in the Treatment of Hyperparathyroidism in Turkish Hemodialysis Patient Population


ALTUNÖREN O., Gungor O., EREN N., Tanrisev M., Hur E., TÜRKMEN K., ...Daha Fazla

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, cilt.25, sa.2, ss.192-198, 2016 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.5262/tndt.2016.1002.12
  • Dergi Adı: TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.192-198
  • Anahtar Kelimeler: Cinacalcet, Chronic renal failure, Hemodialysis, Parathormone, Secondary hyperparathyroidism, PARATHYROID-HORMONE LEVELS, SECONDARY HYPERPARATHYROIDISM, CALCIMIMETIC AGENT, MINERAL METABOLISM, MANAGEMENT, AMG-073, BONE
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

OBJECTIVE: Cinacalcet reduces parathyroid hormone levels by increasing the sensitivity of the parathyroid gland to calcium. In this study, we firstly aimed to evaluate the efficacy of cinacalcet in Turkish hemodialysis patients.